The results of this study provide further clinical evidence that patient-applied, patch-based PSG is a viable alternative to in-lab PSG, enabling broader access to gold-standard sleep testing.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

Please provide your email address to receive an email when new articles are posted on . Electrocardiography data can be put into a neural network to score/determine sleep stages. With ...

A recent review concluded that polysomnography tests have objective value in assessing the effect that socioeconomic status has on sleep quality. In a review published in Clocks and Sleep, a ...

AI can use sleep data from a single night to identify patterns linked to disease risk years before symptoms appear.

The global market for Ambulatory Polysomnography (PSG) systems is projected to grow from USD 309.45 million in 2024 to USD 516.47 million by 2034, reflecting a compound annual growth rate (CAGR) of ...

LONDON--(BUSINESS WIRE)--The global polysomnography devices market size will grow by USD 117.65 million during 2019-2023. This market report provides a detailed analysis of the market by end-users ...